TY  - BOOK
AU  - Ng, Rick
TI  - Drugs: from discovery to approval
SN  - 9781118907276
U1  - 615.32 
PY  - 2015///
CY  - New Jersey
PB  - Wiley Blackwell
KW  - Drug Discovery
KW  - Chemistry, Pharmaceutical
KW  - Clinical Trials as Topic
KW  - methods
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Technology, Pharmaceutical
N1  - Includes bibliographical references and index
N2  - The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. 

Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The third edition incorporates the latest developments and updates in the pharmaceutical community, provides more comprehensive coverage of topics, and includes more materials and case studies suited to college and university use. Biotechnology is a dynamic field with changes across R&D, clinical trials, manufacturing and regulatory processes, and the third edition of the text provides timely updates for those in this rapidly growing field
UR  - https://www.wiley.com/en-be/Drugs%3A+From+Discovery+to+Approval%2C+3rd+Edition-p-9781118907276#tableofcontents-section
UR  - https://www.goodreads.com/book/show/23530327-drugs?ref=nav_sb_ss_1_13#CommunityReviews
ER  -